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Transcriptional Activation of ZEB1 by Slug Leads to
Cooperative Regulation of the Epithelial–Mesenchymal
Transition-Like Phenotype in Melanoma
Christian Wels1,2, Shripad Joshi1,2, Petra Koefinger1,2, Helmut Bergler3 and Helmut Schaider1,2,4
The E-box-binding zinc finger transcription factors Slug and ZEB1 are important repressors of E-cadherin,
contributing to epithelial–mesenchymal transition (EMT) in primary epithelial cancers. Activator or repressor
status of EMT transcription factors defines consequences for tumorigenesis. We show that changes in
expression levels of Slug in melanoma cell lines lead to concomitant alterations of ZEB1 expression.
Electrophoretic mobility shift, luciferase reporter, and chromatin immunoprecipitation assays identified Slug as
a direct transcriptional activator at E-boxes of the ZEB1 promoter. Transcriptional activation of ZEB1 was
demonstrated to be specific for Slug, as EMT regulators Snail and Twist failed to influence ZEB1 expression.
Slug and ZEB1 cooperatively repressed E-cadherin expression resulting in decreased adhesion to human
keratinocytes, but promoted migration of melanoma cells. Our results show that the transcriptional activity of
ZEB1 is increased by Slug, suggesting a hierarchical organized expression of EMT transcription factors through
directed activation, triggering an EMT-like process in melanoma.
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INTRODUCTION
Loss of the epithelial cell adhesion molecule E-cadherin is an
initial step of carcinoma cell lines acquiring a more invasive
phenotype (Behrens et al., 1989; Frixen et al., 1991).
Repression of E-cadherin is mainly mediated by a subset of
E-box-binding transcription factors referred to as epithelial–-
mesenchymal transition regulators (EMTRs). Members in-
clude the zinc finger transcription factors Snail (Batlle et al.,
2000), Slug (Hajra et al., 2002; Bolos et al., 2003), ZEB1 (Eger
et al., 2005), and SIP1 (Comijn et al., 2001), as well as basic
helix–loop–helix transcription factors E12/47 (Perez-Moreno
et al., 2001) and Twist (Yang et al., 2004). These EMTRs are
crucial to the process of epithelial–mesenchymal transition
(EMT), a major determinant of metastasis in melanoma
(Alonso et al., 2007), in which epithelial cells undergo a
conversion into mesenchymal cells. During progression of
epithelial tumors, EMTRs promote proliferation, migration,
and invasion of cancer cells (Thiery, 2003; Huber et al.,
2005; Kalluri and Weinberg, 2009). They also contribute
substantially toward resistance to programed cell death and
senescence, chemo-, and immunotherapy and escape from
immune surveillance (Thiery et al., 2009). In cutaneous
melanoma, EMTRs are reported to have an important role in
gaining independence from keratinocytes as well as progres-
sion toward metastases (Hsu et al., 2000; Poser et al., 2001;
Hoek et al., 2004; Gupta et al., 2005).
The zinc finger EMT regulators, Slug and ZEB1, are potent
repressors of E-cadherin expression and enhancers of migra-
tion and invasion in addition to F-actin remodeling (Bolos
et al., 2003; Bracken et al., 2008; Drake et al., 2009). Slug
regulates integrin expression (Turner et al., 2006), represses
Claudin-1 (Martinez-Estrada et al., 2006), and mediates
resistance to apoptosis (Kajita, McClinic and Wade, 2004).
ZEB1 promotes proliferation in breast cancer (Hu et al., 2010)
and represses several master regulators of epithelial cell
polarity (Aigner et al., 2007; Spaderna et al., 2008) and
basement membrane components (Spaderna et al., 2006).
Among others, ZEB1 has been reported to be upregulated by
transforming growth factor-b (Shirakihara et al., 2007) and
estrogen (Dillner and Sanders, 2002) as well as transcription
factors NF-kB (Chua et al., 2007) and HIF-1 (Krishnamachary
et al., 2006). Recent reports demonstrated ZEB1 to be subject
to negative regulation by the miRNA-200 family and
miRNAs-141 and -205 (Gregory et al., 2008; Brabletz and
Brabletz, 2010). ZEB1 expression was also found to be
promoted by the EMT regulator Snail (Guaita et al., 2002), yet
in an indirect way involving not-yet defined pathways or
transcription factors. Although Slug functions as a repressor of
various genes related to EMT, it also serves as an enhancer of
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A hierarchical organization of EMTR expression in the
course of tumorigenesis may constitute an appealing concept to
better understand the diversity of functions, which have been
ascribed to these transcription factors. In this study, we
demonstrate the direct, Slug-mediated, transcriptional upregu-
lation of ZEB1. Electrophoretic mobility shift, luciferase
reporter, and chromatin immunoprecipitation (ChIP) assays
revealed that Slug is binding to and activating the ZEB1
promoter, leading to a cooperative effect of Slug and ZEB1 in
inducing an EMT-like phenotype of melanoma cells. The
regulation of ZEB1 through Slug is specific, as Snail and Twist
are obviously not directly part of alterations in ZEB1 expression.
RESULTS
Slug regulates ZEB1 expression at the transcriptional level
ZEB1 is regulated by the transforming growth factor-b
signaling pathway (Shirakihara et al., 2007), NF-kB
(Chua et al., 2007), HIF-1 (Krishnamachary et al., 2006), or
the miR-200 family and miR-205 (Gregory et al., 2008). We
investigated a direct transcriptional activation of ZEB1
through Slug. Analyses of ZEB1 levels by immunoblotting
revealed increased ZEB1 expression in melanoma cell lines
WM164 and WM9 transduced with retroviral Slug expression
vector pLXRN-Slug compared with green fluorescent protein
(GFP) control (Figure 1a, b, left panels). This effect was
reversed by silencing of Slug. ZEB1 was downregulated in
both cell lines following Slug silencing (Figure 1a, b, right
panels). ZEB1 mRNA was significantly increased in Slug
overexpressing cells (Figure 1c, left panel), whereas Slug
silencing led to a decrease of ZEB1 transcripts (right panel).
These results suggest that Slug regulates ZEB1 at the
transcriptional level. To prove the specificity of these
findings, we determined whether two related E-box-binding
EMTRs, Snail and Twist, affected ZEB1 protein levels in
WM164 (Figure 1d, e). This was not the case, indicating that
ZEB1 regulation is accomplished through Slug.
Slug binds to E-boxes in the ZEB1 promoter
Slug binds to E-boxes, functioning either as a repressor (Hajra
et al., 2002; Bolos et al., 2003; Martinez-Estrada et al., 2006)
or activator (Moreno-Bueno et al., 2006; Huang et al., 2009)
of transcription. We found four E-boxes at positions –858,
–239, –82, and þ36 of the ZEB1 promoter. To investigate the
binding capacity of Slug to these E-boxes in vitro, electro-
phoretic mobility shift assays (EMSAs) were performed,
incubating nuclear extracts of WM164 (Figure 2, left panel)
or WM9 (Figure 2, right panel) with Cy3-labeled
20-nucleotide fragments each containing one of the four
wild-type or mutated E-boxes. Sequences of the fragments
used for EMSA are provided in Supplementary Table S1
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Figure 1. Slug regulates ZEB1 expression. Immunoblots of whole-cell lysates (15 mg per lane) of transduced melanoma cell lines WM9 (a) and WM164 (b)
overexpressing Slug (pLXRN-Slug) or green fluorescent protein (GFP) control (pLXRN-GFP). Slug knockdown was achieved by transfection with small interfering
RNA (siRNA) against Slug mRNA (siSlug) over a time period of 24–72 hours. Results were compared with unspecific scrambled RNA (scRNA). Samples were
separated on a 10% SDS polyacrylamide gel. After transfer to a polyvinylidene difluoride membrane, blots were probed with antibodies against Slug and ZEB1.
b-Actin was used as a loading control. (c) Analysis of total mRNA extracts of either Slug overexpressing or Slug silenced WM164. Slug, ZEB1, and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA expression was determined by PCR. E-box-binding EMT regulators Snail (d) and Twist (e) were
silenced for 24 and 48 hours using specific siRNAs (siSnail, siTwist). Effects of Snail and Twist silencing on ZEB1 expression were determined by immunoblotting
using indicated antibodies. Numbers represent changes in % of controls and normalized to b-Actin or GAPDH.
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online. After detection of shifted Cy3-labeled DNA fragments
(Figure 2, top panels), DNA–protein complexes were trans-
ferred to polyvinylidene difluoride membranes and subjected
to immunoblotting. In WM164, binding of Slug to all four
wild-type E-box-fragments was observed. With respect to the
fragments of E-box 1, 2, and 3, a single-band-representing
Slug was detected in each case when protein extracts were
incubated with either Cy3-labeled or additional 20-fold
excess of unlabeled wild-type E-box fragments but not with
mutated E-boxes. The same was observed for E-box 4 with the
exception that a second band of higher molecular weight was
detected when a 20-fold excess of wild-type cold probe was
provided, indicating that Slug might be part of a larger
complex binding to the E-box. As Snail has been reported to
affect ZEB1 expression (Guaita et al., 2002), we also
determined its binding capacity to ZEB1 promoter fragments.
Snail binding to fragments containing E-boxes 2 and 4 was
detected only when a 20-fold excess cold probe was
provided additionally to Cy3-labeled probe. It remains
unclear whether the detected bands are nonspecific or if
Snail is binding to E-boxes 2 and 4 specifically, but to a lesser
extent than Slug. Twist, an E-box-binding bHLH transcription
factor, is presumably binding specifically to E-boxes 3 and 4,
as two bands could be detected for the wild type but not for
mutated probes. Interestingly, bands of the same size were
found binding to E-boxes 1 and 2 but only if a 20-fold excess
of cold probe was added (E-box2) or if binding to the mutated
sequence (E-box1). Similar results were obtained when using
nuclear extracts of WM9. Taken together, these results
suggest a preferential binding of Slug to all four wild-type
E-boxes compared with Snail and Twist.
Slug activates the ZEB1 promoter
To confirm the results obtained by mobility shift assays, we
investigated the effect of Slug on activating the ZEB1
promoter. To this end, we cloned a 1,054 bp fragment
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Figure 2. Differential binding of Slug, Snail, and Twist to E-boxes of the ZEB1 promoter. Four Cy3-labeled 20nt wild-type (wt) fragments of the ZEB1 promoter
(wt-Cy3), each containing one out of four potential Slug-binding sites (E-boxes) found in the ZEB1 promoter in a region from 3,000 to þ 200 relative to
the transcription start were incubated with 10 mg of nuclear extracts of WM164 (a) or WM9 (b) in the absence or presence of a 20-fold molar excess cold
probe (20wt unlabeled) for 30minutes at 37 1C in binding buffer. DNA–protein complexes were separated by non-denaturating PAGE (6%) for 45minutes
at 120V and detected by Bio-Rad Molecular Imager FX (electrophoretic mobility shift assay (EMSA)-gel). After detection, complexes where transferred to
polyvinylidene difluoride membrane and subjected to immunoblotting with antibodies against Slug, Snail, and Twist. To prove the specificity of the
binding of EMT regulators to the contributing E-boxes, wild-type sequences CASSTG were mutated to ATSSTA (mut-Cy3).
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covering the region –963 to þ91 relative to the transcription
start (þ 1) of the human ZEB1 promoter into pGL3-basic
luciferase reporter plasmid (pGL3-promZEB1wt). This frag-
ment contains all four E-box-binding sites, each mutated
separately by site-directed mutagenesis PCR. A scheme of the
human ZEB1 promoter as well as wild-type and mutated
luciferase fragments is provided in Figure 3a. COS-7 cells
were co-transfected with reporter plasmids and pcDNA
expression vectors containing GFP, Slug or Twist comple-
mentary DNAs. Figure 3b demonstrates activation of the
ZEB1 promoter through Slug as luciferase activity was
increased 2-fold compared with GFP control. Examination
of luciferase expression driven by ZEB1 promoter fragments
with single mutated E-boxes revealed the highest reduction
when E-box2 (mutE2) was mutated, followed by E-boxes 1, 4,
and 3. As mobility shift assays suggested Twist also binding to
ZEB1 promoter E-boxes, we additionally investigated the
effect of Twist overexpression on luciferase expression. Only
a 28% increase in luciferase activity was observed compared
with GFP control, indicating that Slug rather than Twist has
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Figure 3. Slug enhances the activity of the ZEB1 promoter in COS-7 transfectants. (a) Scheme of the ZEB1 promoter region from 3,000 to þ200 relative to
the transcription start (þ1). Four potential Slug-binding sites (E-boxes) were found and referred to as E-boxes 1–4 (arrowheads). A 1,054 bp fragment harboring
all four E-boxes was amplified out of genomic DNA and ligated into pGL3-basic (Promega) luciferase reporter vector (pGL3-promZEB1). Each of the E-boxes
(mut E1–4) was mutated separately as indicated by asterisks. (b) COS-7 cells were co-transfected with pcDNA-green fluorescent protein (GFP), pcDNA-Twist, or
pcDNA-Slug together with empty vector control (pGL-) or pGL3-promZEB1 wild-type (wt) or mutated E-boxes (mutE1–4). Cells were subjected to luciferase
expression analysis 48 hours after transfection. Luciferase activity is given as meanþ SD relative to activity in GFP control cells. **Po0.01 highly significant.
(c) Slug and Twist overexpression in pcDNA-Slug or -Twist transfected cells was confirmed by immunoblotting. Numbers represent changes in % of controls and
normalized to b-Actin. (d) In vivo binding of Slug but not Twist to the ZEB1 promoter. Chromatin immunoprecipitation was performed with WM164 cells using
two different Slug antibodies (Cell Signaling; Santa Cruz) for immunoprecipitation. ZEB1 promoter-specific primers amplified a 383 bp fragment.
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an impact on ZEB1 promoter regulation. Overexpression of
Slug and Twist in COS-7 cells was confirmed by immuno-
blotting as shown in Figure 3c. To prove these results and
demonstrate binding of Slug to the ZEB1 promoter in WM164
cells in vivo, we performed ChIP assays, using two different
Slug antibodies and one Twist antibody, as well as Histone
H3 as a positive and unspecific IgG as a negative control.
Figure 3d indicates that Slug indeed binds to the ZEB1
promoter, as a specific 383 bp fragment covering E-box1 was
amplified by PCR out of chromatin precipitated using both
Slug and Histone H3 but not Twist or IgG control antibodies.
Slug and ZEB1 cooperatively regulate E-cadherin expression
Slug and ZEB1 have been reported to be repressors of
epithelial (Hajra et al., 2002; Eger et al., 2005; Aigner et al.,
2007) and activators of mesenchymal (Moreno-Bueno et al.,
2006; Graham et al., 2008) markers. To investigate the effects
of Slug and ZEB1 on the expression of E- and N-cadherin as
well as vimentin in melanoma, we performed immunoblot-
ting with lysates of cell lines WM164 and WM9 either
overexpressing Slug or ZEB1, or transfected with small
interfering RNA (siRNA) against both transcription factors.
To investigate on the reversibility of Slug-mediated effects,
ZEB1 was silenced in Slug overexpressing cell lines. In
WM164, a melanoma cell line which expresses both E- and
N-cadherin, both silencing of Slug and ZEB1 led to an
upregulation of E-cadherin, with the most significant effect
obtained when both EMTRs were downregulated simulta-
neously (Figure 4a, left panel). Slug overexpression led to a
downregulation of E-cadherin. This effect was reversed by
silencing of ZEB1, indicating ZEB1 to be a potent repressor of
E-cadherin in melanoma (Figure 4a, middle panel). Over-
expression of ZEB1 alone leads to E-cadherin downregulation
compared with empty vector control (Figure 4a, right panel).
In contrast, N-cadherin and vimentin expression levels were
not significantly altered by any of the chosen conditions in
either WM164 (Figure 4a) or WM9 (Figure 4b).
The effect of Slug and ZEB1 on cell–cell adhesion and cell
migration is additive
Both Slug and ZEB1 have been shown to change functional
properties of cancer cells including adhesion and migration
(Hajra et al., 2002; Eger et al., 2005), accompanied by F-actin
remodeling (Bolos et al., 2003; Bracken et al., 2008).
Overexpression of Slug in WM164 cells led to a repression
of E-cadherin, which in turn was followed by a significant
decrease of adhesion to keratinocytes (Figure 5a). Silencing of
ZEB1 resulted in an almost 2-fold increased adhesion to
keratinocytes in GFP-transduced WM164 and also compen-
sated for the effect obtained by Slug overexpression. In fact,
silencing of ZEB1 in Slug overexpressing cells even increased
adhesion to keratinocytes compared with GFP control cells.
However, decreased binding to keratinocytes was observed
compared with siZEB1 alone, indicating a net effect of Slug
due to ZEB1 activation (Figure 5a). Adhesion to fibroblasts
remained unaltered under the same conditions (Figure 5b) in
line with the results shown in Figure 4, indicating that Slug
and ZEB1 do not influence N-cadherin expression. Silencing
of ZEB1 in WM164 and WM9 not only resulted in a
decreased directed migration of pLXRN-GFP-transduced
cells, but also compensated for the gain in migration obtained
by Slug overexpression in both the cell lines (Figure 5c, d and
Supplementary Figure S1a, b online). These results were
confirmed by wound-healing assays representing random
migration (Figure 5e and Supplementary Figure S1c online).
In addition, we determined the effect of Slug and ZEB1 on
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Figure 4. The effect of Slug and ZEB1 on E-cadherin expression is additive.
Regulation of epithelial and mesenchymal markers through Slug and ZEB1 in
melanoma cell lines WM164 (a) and WM9 (b) was determined by immuno-
blotting. Cells were transfected with either scrambled RNA (scRNA), small
interfering RNA (siRNA) against Slug (siSlug), ZEB1 (siZEB1), or both Slug and ZEB1
(siSlugþ siZEB1) for 48hours (left panels). Stable expression of green fluorescent
protein (GFP) or Slug (pLXRN-GFP, pLXRN-Slug, middle panels) or ZEB1 (pQCXIN-
ZEB1 and empty control vector pQCXIN-cont, right panels) was achieved by
retroviral transduction of WM164 andWM9. Effects of Slug overexpression through
co-activation of ZEB1 were reversed using siRNA against ZEB1 (middle panels).
Samples were separated by 10% SDS polyacrylamide gels, transferred to
polyvinylidene difluoride membrane, and probed by indicated antibodies. E-
cadherin (expressed only in WM164) was chosen as epithelial marker, N-cadherin
and vimentin as mesenchymal markers. b-Actin was used as a loading control.
Numbers represent changes in % of controls and normalized to b-Actin.
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F-actin remodeling in WM164. Results showed that there was
no significant difference between untransduced and Slug-
transduced cells, as both revealed filamentous structures of
stress fibers, however, these structures were lost in ZEB1-
silenced cells (Supplementary Figure S1d online). Cell
proliferation of WM164 and WM9 as determined by MTT
assays was not altered in siSlug, siZEB1, or double silenced
cells (data not shown).
DISCUSSION
The E-box-binding zinc finger transcription factor ZEB1 is as a
repressor of E-cadherin and other epithelial markers as well
as promoter of migration and invasion in various cancer types
(reviewed in Vandewalle et al., 2009; Brabletz and Brabletz,
2010,). Of the E-box binding, EMT regulating transcription
factors, Snail, has been reported to be an enhancer of ZEB1
expression in different cell types including HT-29 M6 colon
cancer cells (Guaita et al., 2002), however, the authors did
not consider Snail to directly regulate ZEB1 at the transcrip-
tional level. A delay of 4 days between the induction of Snail
expression and ZEB1 upregulation was observed and the time
required to activate the ZEB1 promoter in luciferase reporter
assays was longer than the time taken to repress the promoter
of E-cadherin (Guaita et al., 2002). In accordance, Taube
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Figure 5. Slug and ZEB1 cooperate in regulating cell–cell adhesion and migration. To test for Slug and ZEB1-dependent alterations in adhesion to layers
of keratinocytes (a) and fibroblasts (b), ZEB1 was silenced in green fluorescent protein (GFP) or Slug overexpressing WM164. After incubation for 30minutes, non-
adherent cells were removed and adherent cells were counted. The effect of Slug and ZEB1 on directed migration was investigated in GFP or Slug-transduced
WM164 (c) and WM9 (d), transfected with scRNA or siZEB1. DiI-stained cells were seeded in the upper compartment of 8-mm pore size cell culture inserts. Migration
toward the lower compartment was monitored by fluorescent microscope. All results are given as meanþ SD in % compared with GFP control. *Po0.05 significant;
**Po0.01 highly significant. (e) Wound-healing assay (24hours) of GFP or Slug-transduced WM164 transfected with scRNA or siZEB1. Bar¼ 200mm.
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et al. (2010) showed elevated ZEB1 mRNA levels in Snail and
Twist overexpressing HMLE cells. These data suggest that
EMTRs might be involved in ZEB1 regulation. This study now
provides evidence for the specific, transcriptional regulation
of ZEB1 through Slug, but not Snail or Twist in melanoma cell
lines, consistent with the results of Huang et al. (2009), who
reported Slug, but not Snail or Twist to induce expression of
membrane-type 4 matrix metalloproteinase. The proof of a
direct, specific regulation of one EMT transcription factor by
another constitutes an appealing concept of a potential
hierarchy of EMTR expression in the course of melanoma
progression.
Intact E-box sequences have been described as a
requirement for Slug-mediated regulation of E-cadherin
(Hajra et al., 2002; Bolos et al., 2003), Claudin-1 (Marti-
nez-Estrada et al., 2006), integrins (Turner et al., 2006),
occludin (Wang et al., 2007), and membrane-type 4 matrix
metalloproteinase (Huang et al., 2009). Performing EMSAs,
we revealed Slug binding to wild type but not mutated
E-box sequences, which were identified in the ZEB1
promoter in a range from 3,000 to þ200 relative to the
transcription start. Transcriptional activation at these sites
was confirmed by luciferase reporter assays using a 1.054 kbp
ZEB1 promoter fragment containing all four E-boxes.
Introduction of mutations in single E-boxes revealed prefer-
able sites of activation. Slug binds to distinct E-boxes of the
E-cadherin (Hajra et al., 2002) and Claudin (Martinez-Estrada
et al., 2006) promoters with different affinities. Binding the
mouse E-cadherin E-pal sequence was suggested to even
occur in a di- or multimeric form (Bolos et al., 2003).
Similarly, our results indicate that the binding to and
activation of the ZEB1 promoter E-boxes by Slug occurs with
different affinities, in part generating different sized bands on
mobility shift assays. Whether these differences in size
depict multimeres of Slug alone or complexes of Slug
together with other proteins is yet to be determined. As Slug
has been described to mediate its repressing function at least
partially by recruiting C-terminal-binding protein-1 and
histone deacetylase-1 (Tripathi et al., 2005), it is tempting
to speculate that other transcription factors or co-factors
might be involved in Slug-dependent ZEB1 activation as well.
The ZEB1 promoter is induced B2.5-fold by NF-kB subunit
p65 compared with empty vector control (Chua et al., 2007)
and 2-fold by Slug, but only marginally by Twist (this study).
Thus, the affinity of Twist to the ZEB1 promoter may not be
strong enough to result in significant changes of ZEB1 protein
levels, indicating Slug preferentially regulating ZEB1 expres-
sion in melanoma compared with other EMTRs. These
findings are supported by the results of ChIPs, indicating
Slug but not Twist binding to the ZEB1 promoter in vivo.
We assume that Twist may be able to bind to the ZEB1
promoter fragments if provided in in vitro (EMSA) affinity
studies but not in the cellular context, thus, giving evidence
for the specificity of Slug as a ZEB1 regulating transcription
factor.
Activation of ZEB1 transcription by Slug might have
consequences for functionality. To this end the impact of
Slug and ZEB1 on melanoma cell adhesion and migration as
prototypic features of EMT was determined. Specifically, we
focused on the cooperation of the two transcription factors
and the ability of ZEB1 knockdown to at least partially
abrogate the effects obtained by Slug overexpression.
Regarding the regulation of epithelial and mesenchymal
markers, Slug and ZEB1 have been consistently described as
repressors of E-cadherin in various cell lines (Hajra et al.,
2002; Bolos et al., 2003; Eger et al., 2005; Shirakihara et al.,
2007). In prostate cancer cells, N-cadherin has been reported
to be upregulated by ZEB1 by Graham et al. (2008), but not
by Drake et al. (2009). N-cadherin is slightly upregulated in
Slug-transduced MCDK cells (Moreno-Bueno et al., 2006),
whereas it is downregulated in ZEB1-silenced human
esophageal epithelial cells (Ohashi et al., 2010). Shirakihara
et al. (2007) reported ZEB1 to have no influence on the
expression of mesenchymal markers N-cadherin, vimentin,
and fibronectin. In contrast, vimentin is upregulated by ZEB1
in PC-3 cells (Drake et al., 2009), upregulated by Slug in
DLD1 colon cancer (Medici et al., 2008), and OE33
esophageal adenocarcinoma cell lines (Jethwa et al., 2008).
These reports strongly suggest that the effect of Slug and ZEB1
on N-cadherin and vimentin expression may depend on the
cellular background and the microenvironment. In this study,
we demonstrate Slug and ZEB1 to be repressors of E-cadherin
in melanoma, observing an additive effect of both transcrip-
tion factors. Slug-mediated downregulation of E-cadherin
can be reversed by ZEB1 silencing, indicating a cooperative
repressor function of both EMTRs. N-cadherin and vimentin
levels, however, are not affected by overexpression
or silencing of either transcription factor. Respective
changes in E- and N-cadherin expression are reflected by
adhesion assays of melanoma cells to keratinocytes and
fibroblasts.
There is unanimous agreement that both Slug (Bolos et al.,
2003; del Barrio and Nieto, 2002, reviewed in Barrallo-
Gimeno and Nieto, 2005) and ZEB1 (Aigner et al., 2007;
Bracken et al., 2008; Das et al., 2009; Drake et al., 2009) are
inducers of cell migration in various cell types. We were able
to confirm these results in melanoma, again suggesting a
cooperative regulation of Slug and ZEB1, as enhanced
migration after Slug overexpression was reversed by ZEB1
silencing. In addition, it has been shown that F-actin
remodeling from a cortical to a stress-fiber pattern, represent-
ing a more motile phenotype, occurs as a consequence of
Slug (Bolos et al., 2003) and ZEB1 (Bracken et al., 2008)
overexpression. In this study, silencing of ZEB1 in wild-type
and Slug overexpressing metastatic melanoma cell line
WM164 led to an actin rearrangement from a filamentous
to a cortical structure.
Overall, these data demonstrate the direct and specific
upregulation of ZEB1 by Slug, increasing the cooperative
effect of these two transcription factors on EMT. According to
Bolos et al. (2003), who claimed the priority of a rapid and
efficient repression of E-cadherin at initial stages of invasion,
we speculate that a directed regulation of EMT transcription
factors may promptly execute the repression of epithelial
markers, enabling detachment and migration during early
stages of melanomagenesis.
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MATERIALS AND METHODS
Cell culture
Human melanoma cell lines, fibroblasts, and keratinocytes were
kindly provided by Dr Meenhard Herlyn (The Wistar Institute,
Philadelphia, PA). The human metastatic melanoma cell lines WM9
and WM164 were cultured in RPMI 1640 (Sigma Aldrich, St Louis,
MO) supplemented with 2% fetal calf serum and 2% L-glutamine
(PAA, Pasching, Austria). The HEK-293-derived cell line GP-293
(Clontech, Mountain View, CA), stably transfected with gag/pol
genes and used for the production of retroviruses and human
fibroblasts FF2462 were maintained in DMEM (Sigma) containing
10% fetal calf serum and 2% L-glutamine. Monkey COS-7 cells were
cultured in DMEM Nutrient Mixture F-12 HAM (Sigma), supple-
mented with 4% fetal calf serum and 2% L-glutamine. Primary
human keratinocytes FK-181 were kept in Keratinocyte SFM
(Invitrogen, Carlsbad, CA). All cells were maintained at 37 1C in a
humidified atmosphere containing 5% CO2.
RNA inhibition experiments
siRNAs targeting mRNAs of Slug, ZEB1, and Twist were purchased
from Santa Cruz, siRNA against Snail was obtained from Dharmacon
(Lafayette, CO). Control siRNA was purchased from Qiagen, Vienna,
Austria. 150 pmol siRNA were transfected into cells seeded in 6-
well-plates using Lipofectamine 2000 reagent (Invitrogen) following
the manufacturer’s protocol. Cells were processed for immunoblot
analyses or functional assays 24, 48, or 72 hours after transfection.
Vectors and vector production
GFP and Slug complementary DNAs were subcloned into the modified
retroviral vector pLXRN-CMV1, kindly provided by Dr Chengjiang Li
(Department of Medicine, The First Affiliated Hospital, College of
Medicine, Zhejiang University, PR China). pcDNA3.hSlug was a gift of
Dr Pierre Savagner (Batiment de Recherche en Cancerologie,
Montpellier, France). Retroviral pQCXIN-ZEB1 and pQCXIN-cont
vectors were kindly provided by Dr Harikrishna Nakshatri
(Department of Surgery, Indiana University School of Medicine,
Indianapolis, IN). pcDNA4-hTwist was a kind gift of Dr Carlotta
Glackin (Department of Neurosciences, Beckman Research Institute of
City of Hope, Duarte, CA). For luciferase assays, a 1.054kbp fragment
of the ZEB1 promoter covering the region 963 to þ 91 relative to the
transcription start was amplified out of genomic DNA using Phusion
High-Fidelity DNA Polymerase (Finnzymes, Espoo, Finland) and
cloned into pGL3-basic vector (Promega, Madison, WI) using
restriction sites KpnI and HindIII (pGL3-promZEB1wt).
Electrophoretic mobility shift assay
EMSA was performed according to standard protocols, using
20-nucleotide fragments of the ZEB1 promoter containing either
wild-type (CASSTG) or mutated (ATSSTA) E-boxes (Supplementary
Table S1 online). Nuclear extracts (10 mg) of WM9 or WM164 were
incubated with Cy3-labeled double strand oligonucleotides for
30minutes at 37 1C in binding buffer (10mM Tris (pH 7.5), 50mM
NaCl2, 1mM dithiothreitol, 0,1mM EDTA, 5% glycerol) with 1mg of
poly(dI-dC). After incubation the reaction batches were separated by
non-denaturing PAGE (6%). DNA–protein complexes were detected
by Bio-Rad Molecular Imager FX (Bio-Rad, Hercules, CA), trans-
ferred to polyvinylidene difluoride membrane and probed with Slug,
Snail or Twist antibodies by immunoblotting.
Luciferase assay
Slug-dependent ZEB1 promoter activity was determined by co-
transfection of COS-7 cells with pcDNA-GFP, pcDNA-Slug, or
pcDNA-Twist (1.6mg), together with empty pGL3-basic, pGL3-
promZEB1wt, or pGL3-promZEB1 containing mutations in one of four
E-boxes (1.6mg) using Lipofectamine 2000 following the manufac-
turer’s protocol for transfection in 12-well-plates. Luciferase activity
was measured 48hours post-transfection using the Luciferase Assay
System from Promega and normalized to 1mg of protein. Detection
was done using LUMIstar Omega luminometer (BMG Labtech,
Offenburg, Germany). Experiments were performed in triplicate.
Chromatin immunoprecipitation
ChIP was performed using SimpleChIP Enzymatic Chromatin IP Kit
(Cell Signaling, Danvers, MA), following the manufacturer’s proto-
col. In brief, 4 107 WM164 cells were crosslinked with 1%
formaldehyde for 30minutes. After isolation of nuclei, chromatin
was digested by micrococcal nuclease (15,000 gel units) for
20minutes at 37 1C. Subsequently, the nuclear membrane was
disrupted by an UP50H Ultrasonic Processor (Dr Hielscher GmbH,
Tetlow, Germany), duty cycle 1, 100% amplitude, 4 20 seconds.
For immunoprecipitation, 100 ml (B15 mg of chromatin DNA) of the
crosslinked chromatin preparation were incubated over night at 4 1C
with the following antibodies: Twist [2C1a] (Abcam, Cambridge,
UK, dilution 1:50), Slug [L40C6] (Cell Signaling, dilution 1:50), Slug
[G-18] (Santa Cruz, dilution 1:50). Histone H3 [D2B12] and normal
rabbit IgG, both provided by the ChIP kit, were used as a positive or
negative control, respectively. After incubation with 30 ml Protein G
Agarose Beads (2 hours, 4 1C, rotation), antibody–DNA complexes
were washed, eluted from the beads and Proteinase K digested for
2 hours at 65 1C. Following spin column-based DNA purification,
PCR was performed using ZEB1 promoter-specific primers 50-TCATG
GCCTGTGGATACCTTAGC-30 (forward) and 50-TTTGGGGACGGC
GAGGA-30 (reverse), producing a 383 bp fragment.
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